The present invention relates to a pharmaceutical composition for use in the treatment of pre-cancerous conditions of the cervix/anogenital region, non-melanoma skin cancers (NMSCs), or actinic keratosis wherein said composition comprises a surfactant, preferably an anionic or amphoteric surfactant.
